United States · FDA National Drug Code directory
CARBIDOPA, LEVODOPA AND ENTACAPONE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16571-693_4d1e7e53-059c-4a41-86b0-66d20ce660d0
- Product NDC
- 16571-693
- Form
- TABLET, FILM COATED
- Composition / generic term
- CARBIDOPA, LEVODOPA AND ENTACAPONE
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210805
- Source listing expiry
- 20271231
Source-listed ingredients
- CARBIDOPA — 37.5 mg/1
- LEVODOPA — 150 mg/1
- ENTACAPONE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (16571-693-01) · 16571-693-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →